Context                Previous, Next                Top


44_a_factbook_1_2010
disease progresses rapidly and without antibiotic treatment leads to pneumonic form with a death rate in excess of 50 <percnt>.

%3 r_0044_0002__progresses progresses r_0044_0001__disease disease r_0044_0002__progresses->r_0044_0001__disease [arg0] r_0044_0003__rapidly rapidly r_0044_0002__progresses->r_0044_0003__rapidly [nim] r_0044_0004__and and r_0044_0004__and->r_0044_0002__progresses [conj1] r_0044_0008__leads leads r_0044_0004__and->r_0044_0008__leads [conj2] r_0044_0008__leads->r_0044_0001__disease [arg0] r_0044_0007__treatment treatment r_0044_0008__leads->r_0044_0007__treatment without [nim] r_0044_0011__form form r_0044_0008__leads->r_0044_0011__form to [clr] r_0044_0006__antibiotic antibiotic r_0044_0007__treatment->r_0044_0006__antibiotic [attrib] r_0044_0010__pneumonic pneumonic r_0044_0011__form->r_0044_0010__pneumonic [attrib] r_0044_0013__a_r_0044_0014__death_r_0044_0015__rate a death rate r_0044_0011__form->r_0044_0013__a_r_0044_0014__death_r_0044_0015__rate with r_0044_0017__excess excess r_0044_0013__a_r_0044_0014__death_r_0044_0015__rate->r_0044_0017__excess in r_0044_0019__50_r_0044_0020___percnt_ 50  percnt r_0044_0017__excess->r_0044_0019__50_r_0044_0020___percnt_ of 
arc(r_0044_0002__progresses, r_0044_0001__disease, arg0).
arc(r_0044_0002__progresses, r_0044_0003__rapidly, nim9).
arc(r_0044_0004__and, r_0044_0002__progresses, conj1).
arc(r_0044_0004__and, r_0044_0008__leads, conj2).
arc(r_0044_0007__treatment, r_0044_0006__antibiotic, attrib20).
arc(r_0044_0008__leads, r_0044_0001__disease, arg0).
arc(r_0044_0008__leads, r_0044_0007__treatment, r_0044_0005__without_nim19).
arc(r_0044_0008__leads, r_0044_0011__form, r_0044_0009__to_clr30).
arc(r_0044_0011__form, r_0044_0010__pneumonic, attrib31).
arc(r_0044_0011__form, r_0044_0013__a_r_0044_0014__death_r_0044_0015__rate, r_0044_0012__with).
arc(r_0044_0013__a_r_0044_0014__death_r_0044_0015__rate, r_0044_0017__excess, r_0044_0016__in).
arc(r_0044_0017__excess, r_0044_0019__50_r_0044_0020___percnt_, r_0044_0018__of).


%3 r_0044_0002__progresses progresses r_0044_0001__disease disease r_0044_0002__progresses->r_0044_0001__disease [arg0] r_0044_0003__rapidly rapidly r_0044_0002__progresses->r_0044_0003__rapidly [nim] r_0044_0004__and and r_0044_0004__and->r_0044_0002__progresses [conj1] r_0044_0008__leads leads r_0044_0004__and->r_0044_0008__leads [conj2] r_0044_0008__leads->r_0044_0001__disease [arg0] r_0044_0007__treatment treatment r_0044_0008__leads->r_0044_0007__treatment without [nim] r_0044_0011__form form r_0044_0008__leads->r_0044_0011__form to [clr] r_0044_0006__antibiotic antibiotic r_0044_0007__treatment->r_0044_0006__antibiotic [attrib] r_0044_0010__pneumonic pneumonic r_0044_0011__form->r_0044_0010__pneumonic [attrib] r_0044_0013__a_r_0044_0014__death_r_0044_0015__rate a death rate r_0044_0011__form->r_0044_0013__a_r_0044_0014__death_r_0044_0015__rate with r_0044_0017__excess excess r_0044_0013__a_r_0044_0014__death_r_0044_0015__rate->r_0044_0017__excess in r_0044_0019__50_r_0044_0020___percnt_ 50  percnt r_0044_0017__excess->r_0044_0019__50_r_0044_0020___percnt_ of 
fof(formula,axiom,
    ? [R_44_4_AND,R_44_2_PROGRESSES,R_44_3_RAPIDLY,R_44_8_LEADS,R_44_1_DISEASE,R_44_7_TREATMENT,R_44_6_ANTIBIOTIC,R_44_11_FORM,R_44_10_PNEUMONIC,R_44_13_A_DEATH_RATE,R_44_17_EXCESS,R_44_19_50_PERCNT_] :
      ( rapidly(R_44_3_RAPIDLY)
      & disease(R_44_1_DISEASE)
      & antibiotic(R_44_6_ANTIBIOTIC)
      & pneumonic(R_44_10_PNEUMONIC)
      & 50_percnt_(R_44_19_50_PERCNT_)
      & and(R_44_4_AND)
      & conj1(R_44_4_AND,R_44_2_PROGRESSES)
      & progresses(R_44_2_PROGRESSES,R_44_1_DISEASE)
      & nim9(R_44_2_PROGRESSES,R_44_3_RAPIDLY)
      & conj2(R_44_4_AND,R_44_8_LEADS)
      & leads(R_44_8_LEADS,R_44_1_DISEASE)
      & without_nim19(R_44_8_LEADS,R_44_7_TREATMENT)
      & treatment(R_44_7_TREATMENT)
      & attrib20(R_44_7_TREATMENT,R_44_6_ANTIBIOTIC)
      & to_clr30(R_44_8_LEADS,R_44_11_FORM)
      & form(R_44_11_FORM)
      & attrib31(R_44_11_FORM,R_44_10_PNEUMONIC)
      & with(R_44_11_FORM,R_44_13_A_DEATH_RATE)
      & a_death_rate(R_44_13_A_DEATH_RATE)
      & in(R_44_13_A_DEATH_RATE,R_44_17_EXCESS)
      & excess(R_44_17_EXCESS)
      & of(R_44_17_EXCESS,R_44_19_50_PERCNT_) ) ).


n44_a_factbook_1_2010 n44_a_factbook_1_2010_4 disease n44_a_factbook_1_2010_8 progresses n44_a_factbook_1_2010_11 rapidly n44_a_factbook_1_2010_14 and n44_a_factbook_1_2010_18 without n44_a_factbook_1_2010_22 antibiotic n44_a_factbook_1_2010_24 treatment n44_a_factbook_1_2010_26 leads n44_a_factbook_1_2010_29 to n44_a_factbook_1_2010_33 pneumonic n44_a_factbook_1_2010_35 form n44_a_factbook_1_2010_38 with n44_a_factbook_1_2010_41 a n44_a_factbook_1_2010_43 death n44_a_factbook_1_2010_45 rate n44_a_factbook_1_2010_48 in n44_a_factbook_1_2010_51 excess n44_a_factbook_1_2010_54 of n44_a_factbook_1_2010_57 50 n44_a_factbook_1_2010_59 <percnt> n44_a_factbook_1_2010_61 . n44_a_factbook_1_2010_1 IP-MAT n44_a_factbook_1_2010_2 NP-SBJ n44_a_factbook_1_2010_1->n44_a_factbook_1_2010_2 n44_a_factbook_1_2010_5 ILYR n44_a_factbook_1_2010_1->n44_a_factbook_1_2010_5 n44_a_factbook_1_2010_60 PUNC n44_a_factbook_1_2010_1->n44_a_factbook_1_2010_60 n44_a_factbook_1_2010_3 N n44_a_factbook_1_2010_2->n44_a_factbook_1_2010_3 n44_a_factbook_1_2010_3->n44_a_factbook_1_2010_4 n44_a_factbook_1_2010_6 ILYR n44_a_factbook_1_2010_5->n44_a_factbook_1_2010_6 n44_a_factbook_1_2010_12 CONJP n44_a_factbook_1_2010_5->n44_a_factbook_1_2010_12 n44_a_factbook_1_2010_7 VBP;_I_ n44_a_factbook_1_2010_6->n44_a_factbook_1_2010_7 n44_a_factbook_1_2010_9 ADVP-NIM n44_a_factbook_1_2010_6->n44_a_factbook_1_2010_9 n44_a_factbook_1_2010_7->n44_a_factbook_1_2010_8 n44_a_factbook_1_2010_10 ADV n44_a_factbook_1_2010_9->n44_a_factbook_1_2010_10 n44_a_factbook_1_2010_10->n44_a_factbook_1_2010_11 n44_a_factbook_1_2010_13 CONJ n44_a_factbook_1_2010_12->n44_a_factbook_1_2010_13 n44_a_factbook_1_2010_15 ILYR n44_a_factbook_1_2010_12->n44_a_factbook_1_2010_15 n44_a_factbook_1_2010_13->n44_a_factbook_1_2010_14 n44_a_factbook_1_2010_16 PP-NIM n44_a_factbook_1_2010_15->n44_a_factbook_1_2010_16 n44_a_factbook_1_2010_25 VBP;_Ipr_ n44_a_factbook_1_2010_15->n44_a_factbook_1_2010_25 n44_a_factbook_1_2010_27 PP-CLR n44_a_factbook_1_2010_15->n44_a_factbook_1_2010_27 n44_a_factbook_1_2010_17 P-ROLE n44_a_factbook_1_2010_16->n44_a_factbook_1_2010_17 n44_a_factbook_1_2010_19 NP n44_a_factbook_1_2010_16->n44_a_factbook_1_2010_19 n44_a_factbook_1_2010_17->n44_a_factbook_1_2010_18 n44_a_factbook_1_2010_20 ADJP n44_a_factbook_1_2010_19->n44_a_factbook_1_2010_20 n44_a_factbook_1_2010_23 N n44_a_factbook_1_2010_19->n44_a_factbook_1_2010_23 n44_a_factbook_1_2010_21 ADJ n44_a_factbook_1_2010_20->n44_a_factbook_1_2010_21 n44_a_factbook_1_2010_21->n44_a_factbook_1_2010_22 n44_a_factbook_1_2010_23->n44_a_factbook_1_2010_24 n44_a_factbook_1_2010_25->n44_a_factbook_1_2010_26 n44_a_factbook_1_2010_28 P-ROLE n44_a_factbook_1_2010_27->n44_a_factbook_1_2010_28 n44_a_factbook_1_2010_30 NP n44_a_factbook_1_2010_27->n44_a_factbook_1_2010_30 n44_a_factbook_1_2010_28->n44_a_factbook_1_2010_29 n44_a_factbook_1_2010_31 ADJP n44_a_factbook_1_2010_30->n44_a_factbook_1_2010_31 n44_a_factbook_1_2010_34 N n44_a_factbook_1_2010_30->n44_a_factbook_1_2010_34 n44_a_factbook_1_2010_36 PP n44_a_factbook_1_2010_30->n44_a_factbook_1_2010_36 n44_a_factbook_1_2010_32 ADJ n44_a_factbook_1_2010_31->n44_a_factbook_1_2010_32 n44_a_factbook_1_2010_32->n44_a_factbook_1_2010_33 n44_a_factbook_1_2010_34->n44_a_factbook_1_2010_35 n44_a_factbook_1_2010_37 P-ROLE n44_a_factbook_1_2010_36->n44_a_factbook_1_2010_37 n44_a_factbook_1_2010_39 NP n44_a_factbook_1_2010_36->n44_a_factbook_1_2010_39 n44_a_factbook_1_2010_37->n44_a_factbook_1_2010_38 n44_a_factbook_1_2010_40 D n44_a_factbook_1_2010_39->n44_a_factbook_1_2010_40 n44_a_factbook_1_2010_42 N n44_a_factbook_1_2010_39->n44_a_factbook_1_2010_42 n44_a_factbook_1_2010_44 N n44_a_factbook_1_2010_39->n44_a_factbook_1_2010_44 n44_a_factbook_1_2010_46 PP n44_a_factbook_1_2010_39->n44_a_factbook_1_2010_46 n44_a_factbook_1_2010_40->n44_a_factbook_1_2010_41 n44_a_factbook_1_2010_42->n44_a_factbook_1_2010_43 n44_a_factbook_1_2010_44->n44_a_factbook_1_2010_45 n44_a_factbook_1_2010_47 P-ROLE n44_a_factbook_1_2010_46->n44_a_factbook_1_2010_47 n44_a_factbook_1_2010_49 NP n44_a_factbook_1_2010_46->n44_a_factbook_1_2010_49 n44_a_factbook_1_2010_47->n44_a_factbook_1_2010_48 n44_a_factbook_1_2010_50 N n44_a_factbook_1_2010_49->n44_a_factbook_1_2010_50 n44_a_factbook_1_2010_52 PP n44_a_factbook_1_2010_49->n44_a_factbook_1_2010_52 n44_a_factbook_1_2010_50->n44_a_factbook_1_2010_51 n44_a_factbook_1_2010_53 P-ROLE n44_a_factbook_1_2010_52->n44_a_factbook_1_2010_53 n44_a_factbook_1_2010_55 NP n44_a_factbook_1_2010_52->n44_a_factbook_1_2010_55 n44_a_factbook_1_2010_53->n44_a_factbook_1_2010_54 n44_a_factbook_1_2010_56 NUM n44_a_factbook_1_2010_55->n44_a_factbook_1_2010_56 n44_a_factbook_1_2010_58 N n44_a_factbook_1_2010_55->n44_a_factbook_1_2010_58 n44_a_factbook_1_2010_56->n44_a_factbook_1_2010_57 n44_a_factbook_1_2010_58->n44_a_factbook_1_2010_59 n44_a_factbook_1_2010_60->n44_a_factbook_1_2010_61 
( (IP-MAT (NP-SBJ (N disease;{disease}))
          (ILYR (ILYR (VBP;_I_ progresses;{progress})
                      (ADVP-NIM (ADV rapidly;{rapidly})))
                (CONJP (CONJ and;{and})
                       (ILYR (PP-NIM (P-ROLE without;{without})
                                     (NP (ADJP (ADJ antibiotic;{antibiotic}))
                                         (N treatment;{treatment})))
                             (VBP;_Ipr_ leads;{lead[to]})
                             (PP-CLR (P-ROLE to;{to})
                                     (NP (ADJP (ADJ pneumonic;{pneumonic}))
                                         (N form;{form})
                                         (PP (P-ROLE with;{with})
                                             (NP (D a;{a})
                                                 (N death;{death})
                                                 (N rate;{rate})
                                                 (PP (P-ROLE in;{in})
                                                     (NP (N excess;{excess})
                                                         (PP (P-ROLE of;{of})
                                                             (NP (NUM 50)
                                                                 (N <percnt>))))))))))))
          (PUNC .))
  (ID 44_a_factbook_1_2010))